Urinary metabolomics provide insights into coronary artery disease in individuals with type 1 diabetes

被引:0
|
作者
Antikainen, Anni A. [1 ,2 ,3 ,4 ]
Mutter, Stefan [1 ,2 ,3 ,4 ]
Harjutsalo, Valma [1 ,2 ,3 ,4 ]
Thorn, Lena M. [1 ,2 ,3 ,4 ,5 ,6 ]
Groop, Per-Henrik [1 ,2 ,3 ,4 ,7 ,8 ]
Sandholm, Niina [1 ,2 ,3 ,4 ]
机构
[1] Folkhalsan Inst Genet, Folkhalsan Res Ctr, Helsinki 00290, Finland
[2] Univ Helsinki, Dept Nephrol, Helsinki 00290, Finland
[3] Helsinki Univ Hosp, Helsinki 00290, Finland
[4] Univ Helsinki, Fac Med, Res Program Clin & Mol Metab, Helsinki 00290, Finland
[5] Univ Helsinki, Dept Gen Pract & Primary Hlth Care, Helsinki, Finland
[6] Helsinki Univ Hosp, Helsinki 00014, Finland
[7] Monash Univ, Cent Clin Sch, Dept Diabet, Melbourne, Vic, Australia
[8] Baker Heart & Diabet Inst, Melbourne, Vic, Australia
关键词
Type; 1; diabetes; Coronary artery disease; Cardiac complication; Metabolomics; Urine; Oxidative stress; Survival modeling; Network analysis; Machine learning; CHRONIC KIDNEY-DISEASE; CARDIOVASCULAR-DISEASE; ENDOTHELIAL DYSFUNCTION; INSULIN-RESISTANCE; OXIDATIVE STRESS; RISK; POPULATION; ACID; IDENTIFICATION; NEPHROPATHY;
D O I
10.1186/s12933-024-02512-8
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BackgroundType 1 diabetes increases the risk of coronary artery disease (CAD). High-throughput metabolomics may be utilized to identify metabolites associated with disease, thus, providing insight into disease pathophysiology, and serving as predictive markers in clinical practice. Urine is less tightly regulated than blood, and therefore, may enable earlier discovery of disease-associated markers. We studied urine metabolomics in relation to incident CAD in individuals with type 1 diabetes.MethodsWe prospectively studied CAD in 2501 adults with type 1 diabetes from the Finnish Diabetic Nephropathy Study. 209 participants experienced incident CAD within the 10-year follow-up. We analyzed the baseline urine samples with a high-throughput targeted urine metabolomics platform, which yielded 54 metabolites. With the data, we performed metabolome-wide survival analyses, correlation network analyses, and metabolomic state profiling for prediction of incident CAD.ResultsUrinary 3-hydroxyisobutyrate was associated with decreased 10-year incident CAD, which according to the network analysis, likely reflects younger age and improved kidney function. Urinary xanthosine was associated with 10-year incident CAD. In the network analysis, xanthosine correlated with baseline urinary allantoin, which is a marker of oxidative stress. In addition, urinary trans-aconitate and 4-deoxythreonate were associated with decreased 5-year incident CAD. Metabolomic state profiling supported the usage of CAD-associated urinary metabolites to improve prediction accuracy, especially during shorter follow-up. Furthermore, urinary trans-aconitate and 4-deoxythreonate were associated with decreased 5-year incident CAD. The network analysis further suggested glomerular filtration rate to influence the urinary metabolome differently between individuals with and without future CAD.ConclusionsWe have performed the first high-throughput urinary metabolomics analysis on CAD in individuals with type 1 diabetes and found xanthosine, 3-hydroxyisobutyrate, trans-aconitate, and 4-deoxythreonate to be associated with incident CAD. In addition, metabolomic state profiling improved prediction of incident CAD.
引用
收藏
页数:15
相关论文
共 50 条
  • [1] High urinary dimethylamine and low urinary citrate are associated with coronary artery disease in individuals with type 1 diabetes
    Antikainen, A.
    Mutter, S.
    Sandholm, N.
    Forsblom, C.
    Wurtz, P.
    Harjutsalo, V.
    Groop, P. -H.
    DIABETOLOGIA, 2020, 63 (SUPPL 1) : S50 - S51
  • [2] Type 1 diabetes and coronary artery disease
    Orchard, Trevor J.
    Costacou, Tina
    Kretowski, Adam
    Nesto, Richard W.
    DIABETES CARE, 2006, 29 (11) : 2528 - 2538
  • [3] Coronary artery calcification as a predictor of coronary artery disease in type 1 diabetes
    Huskey, ND
    Olson, J
    Orchard, TJ
    DIABETES, 2001, 50 : A156 - A156
  • [4] Genome-wide association study on coronary artery disease in individuals with type 1 diabetes
    Sandholm, N.
    Valo, E.
    Dahlstrom, E. H.
    Forsblom, C.
    Harjutsalo, V.
    Groop, P. -H.
    DIABETOLOGIA, 2018, 61 : S550 - S551
  • [5] Genetic risk for coronary artery disease in individuals with or without type 2 diabetes
    Yamada, Y
    Ichihara, S
    Izawa, H
    Tanaka, M
    Yokota, M
    MOLECULAR GENETICS AND METABOLISM, 2004, 81 (04) : 282 - 290
  • [6] Coronary calcification as a predictor of coronary artery disease in type 1 diabetes
    Orchard, TJ
    Costacou, T
    Edmundowicz, D
    CIRCULATION, 2006, 113 (08) : E361 - E361
  • [7] New insights in diabetes and coronary artery disease
    Nesto, RW
    ATHEROSCLEROSIS XI, 1998, 1155 : 239 - 247
  • [8] Genetic Risk Score Enhances Coronary Artery Disease Risk Prediction in Individuals With Type 1 Diabetes
    Lithovius, Raija
    Antikainen, Anni A.
    Mutter, Stefan
    Valo, Erkka
    Forsblom, Carol
    Harjutsalo, Valma
    Sandholm, Niina
    Groop, Per-Henrik
    DIABETES CARE, 2022, 45 (03) : 734 - 741
  • [9] Skin Intrinsic Fluorescence Is Associated With Coronary Artery Disease in Individuals With Long Duration of Type 1 Diabetes
    Conway, Baqiyyah N.
    Aroda, Vanita R.
    Maynard, John D.
    Matter, Nathaniel
    Fernandez, Stephen
    Ratner, Robert E.
    Orchard, Trevor J.
    DIABETES CARE, 2012, 35 (11) : 2331 - 2336
  • [10] Urinary protein biomarkers predict development of coronary artery disease in adults with and without type 1 diabetes
    Snell-Bergeon, Janet K.
    Maahs, David
    Ogden, Lorraine G.
    Kinney, Gregory L.
    Hokanson, John E.
    Schiffer, Eric
    Mischak, Harald
    Rewers, Marian
    DIABETES, 2008, 57 : A196 - A197